Endurant Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,563
| Closed | -$3.11M | – | 58 |
|
|
2021
Q2 | $3.11M | Buy |
+5,563
| New | +$3.11M | 0.85% | 40 |
|
|
2020
Q1 | – | Sell |
-27,390
| Closed | -$10.3M | – | 63 |
|
|
2019
Q4 | $10.3M | Buy |
+27,390
| New | +$10.3M | 3.24% | 10 |
|
|
2018
Q3 | – | Sell |
-5,300
| Closed | -$1.83M | – | 82 |
|
|
2018
Q2 | $1.83M | Buy |
5,300
+3,100
| +141% | +$1.07M | 0.79% | 33 |
|
|
2018
Q1 | $758K | Sell |
2,200
-3,400
| -61% | -$1.17M | 0.28% | 58 |
|
|
2017
Q4 | $2.11M | Buy |
+5,600
| New | +$2.11M | 0.64% | 47 |
|
|
2017
Q2 | – | Sell |
-1,300
| Closed | -$504K | – | 99 |
|
|
2017
Q1 | $504K | Sell |
1,300
-900
| -41% | -$349K | 0.16% | 77 |
|
|
2016
Q4 | $808K | Buy |
+2,200
| New | +$808K | 0.33% | 57 |
|
|
2016
Q1 | – | Sell |
-746
| Closed | -$405K | – | 90 |
|
|
2015
Q4 | $405K | Sell |
746
-1,654
| -69% | -$898K | 0.14% | 73 |
|
|
2015
Q3 | $1.12M | Buy |
+2,400
| New | +$1.12M | 0.37% | 58 |
|